CVS Health reported a 6.2% increase in first-quarter revenues to $100.4 billion, with GAAP diluted EPS rising to $2.30 from $1.41 last year. Adjusted EPS also grew to $2.57, driven by improved performance in its Health Care Benefits segment. The company raised its full-year 2026 guidance for GAAP diluted EPS to $6.24-$6.44 and adjusted EPS to $7.30-$7.50, reflecting strong segment growth despite cautious outlook on cost trends and macroeconomic risks. CVS continues to expand services and improve operational efficiency across its segments, aiming to simplify healthcare access and affordability.
Aetna's latest survey shows U.S. healthcare providers' trust in payers increased to a score of 6.1 from 5.4, reflecting improved perceptions of payer reliability and communication. Providers highlight technology's role in reducing administrative task...
CVS Caremark announced a global settlement with the Federal Trade Commission (FTC) resolving all litigation related to rebate practices, pharmacy network contracting, and vertical integration. The agreement ends ongoing investigations and allows CVS ...
